19-11-2021, 09:16 AM
https://www.google.com/search?q=valneva+...hare+price&oq=valneva+nasda&aqs=chrome.1.0i512l2j69i57j0i512l4j0i22i30l3.6310j1j15&sourceid=chrome&ie=UTF-8
19-11-2021, 09:16 AM
19-11-2021, 09:21 AM
Valneva Reports Nine-Month 2021 Revenue and Cash
Inactivated COVID-19 Vaccine Candidate VLA2001
Positive pivotal Phase 3 Results reported
Superiority in terms of neutralizing antibody titer levels compared to comparator vaccine, AstraZeneca’s AZD1222
Non-inferiority in terms of seroconversion rates
Significantly better tolerability profile than comparator
Advance Purchase Agreement approved by European Commission (EC) for up to
60 million doses
https://www.globenewswire.com/news-relea...-Cash.html
Inactivated COVID-19 Vaccine Candidate VLA2001
Positive pivotal Phase 3 Results reported
Superiority in terms of neutralizing antibody titer levels compared to comparator vaccine, AstraZeneca’s AZD1222
Non-inferiority in terms of seroconversion rates
Significantly better tolerability profile than comparator
Advance Purchase Agreement approved by European Commission (EC) for up to
60 million doses
https://www.globenewswire.com/news-relea...-Cash.html
19-11-2021, 09:51 AM
AstraZeneca Covid antibody treatment ‘more effective than vaccines after six months’
https://sg.yahoo.com/news/astrazenecas-c...32045.html
https://sg.yahoo.com/news/astrazenecas-c...32045.html